Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis (vol 41, pg 541, 1998)

被引：0
|
作者：
Barchiesi, F
Arzeni, D
Del Prete, MS
Sinicco, A
Di Francesco, LF
Pasticci, MB
Lamura, L
Nuzzo, MM
Burzacchini, F
Coppola, S
Chiodo, F
Scalise, G
机构：
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1998年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [1] Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis
    Barchiesi, F
    Arzeni, D
    Del Prete, MS
    Sinicco, A
    Di Francesco, LF
    Pasticci, MB
    Lamura, L
    Nuzzo, MM
    Burzacchini, F
    Coppola, S
    Chiodo, F
    Scalise, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) : 541 - 548
  • [2] Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis
    Dannaoui, E
    Lacoste, V
    Prat, C
    Piens, MA
    [J]. MYCOSES, 1997, 40 (7-8) : 279 - 282
  • [3] Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
    Martínez, M
    López-Ribot, JL
    Kirkpatrick, WR
    Bachmann, SP
    Perea, S
    Ruesga, MT
    Patterson, TF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 515 - 524
  • [4] Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis
    Salari, S.
    Khosravi, A. R.
    Mousavi, S. A. A.
    Nikbakht-Brojeni, G. H.
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 2016, 26 (01): : 35 - 41
  • [5] ORAL CANDIDA-ALBICANS ISOLATES WITH REDUCED SUSCEPTIBILITY TO FLUCONAZOLE IN SWEDISH HIV-INFECTED PATIENTS
    CHRYSSANTHOU, E
    TORSSANDER, J
    PETRINI, B
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (04) : 391 - 395
  • [6] Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis
    Müller, FMC
    Weig, M
    Peter, J
    Walsh, TJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) : 338 - 341
  • [7] Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil
    Goldman, GH
    Ferreira, MED
    Marques, ED
    Savoldi, M
    Perlin, D
    Park, S
    Martinez, PCG
    Goldman, MHS
    Colombo, AL
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 25 - 32
  • [8] CORRELATION BETWEEN IN-VITRO SUSCEPTIBILITY OF CANDIDA-ALBICANS AND FLUCONAZOLE-RESISTANT OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS
    TROILLET, N
    DURUSSEL, C
    BILLE, J
    GLAUSER, MP
    CHAVE, JP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (12) : 911 - 915
  • [9] Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans
    Laguna, F
    RodriguezTudela, JL
    MartinezSuarez, JV
    Polo, R
    Valencia, E
    DiazGuerra, TM
    Dronda, F
    Pulido, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 124 - 130
  • [10] ACTIVITY OF FLUCONAZOLE AGAINST CANDIDA-ALBICANS ISOLATES FROM HIV + PATIENTS IN A DIGESTIVE CANDIDOSIS TURKEY MODEL
    REYNES, J
    MALLIE, M
    RAVISSE, P
    BASTIDE, JM
    [J]. JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1992, 30 (05): : 363 - 367
12345